BUY Glenmark Pharmaceuticals — Manas Jaiswal, 09 Oct 2026

BUYGlenmark Pharmaceuticals

Glenmark Pharmaceuticals share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))9 Oct 2026via CNBC Awaaz.

Entry₹2,275Inferred

Target₹2,375

Total upside +4.40%

Stop loss₹2,250-1.10% risk

CMP₹2,283Just now

Active+0.35%+4.03%upside left 14d left

Follow Manas Jaiswal for new calls(30% target hit, 351 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 1 other Swing call on GLENMARK See 84 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 12 Oct, 4:45 pm IST

6 supporting1 opposing

Supports the BUY call (6)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·9 Oct · 3d ago

Glenmark Therapeutics Inc. USA has launched Pump Packs for Adapalene Gel USP, 0.1% (OTC), expanding its product portfolio in the US market.

BSE · Company Update·6 Oct · 6d ago

Glenmark Therapeutics Inc., a subsidiary of Glenmark Pharmaceuticals, has launched Pump Packs for Adapalene Gel USP, 0.1% (OTC) in the United States.

NSE · Press Release·6 Oct · 6d ago

Glenmark expects innovative drugs to drive higher revenue share: CMD Glenn Saldanha

NewsCnbc-Tv18·5 Oct · 1w ago

Glenmark Pharma FY26 PAT Rises 30.1% to ₹13,620 Million; Q4 EBITDA Jumps to ₹9.4b

NewsGoogle News·27 Sept · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·12 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Manas Jaiswal

Every call and its outcome